A detailed history of Federated Hermes, Inc. transactions in Argenx Se stock. As of the latest transaction made, Federated Hermes, Inc. holds 211,144 shares of ARGX stock, worth $133 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
211,144
Previous 254,390 17.0%
Holding current value
$133 Million
Previous $109 Million 4.67%
% of portfolio
0.26%
Previous 0.27%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$434.22 - $551.9 $18.8 Million - $23.9 Million
-43,246 Reduced 17.0%
211,144 $115 Million
Q2 2024

Aug 08, 2024

SELL
$356.01 - $451.55 $5 Million - $6.34 Million
-14,044 Reduced 5.23%
254,390 $109 Million
Q1 2024

May 14, 2024

SELL
$356.95 - $413.29 $31.4 Million - $36.4 Million
-88,073 Reduced 24.7%
268,434 $106 Million
Q4 2023

Jan 31, 2024

BUY
$338.91 - $506.01 $8.27 Million - $12.4 Million
24,416 Added 7.35%
356,507 $136 Million
Q3 2023

Nov 13, 2023

SELL
$369.35 - $548.43 $787,454 - $1.17 Million
-2,132 Reduced 0.64%
332,091 $163 Million
Q2 2023

Aug 14, 2023

SELL
$360.14 - $422.58 $4.32 Million - $5.07 Million
-11,991 Reduced 3.46%
334,223 $130 Million
Q1 2023

May 08, 2023

SELL
$334.23 - $403.65 $11 Million - $13.2 Million
-32,797 Reduced 8.65%
346,214 $129 Million
Q4 2022

Feb 13, 2023

SELL
$342.17 - $402.31 $22.1 Million - $26 Million
-64,626 Reduced 14.57%
379,011 $144 Million
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $67,267 - $77,567
196 Added 0.04%
443,637 $157 Million
Q2 2022

Aug 15, 2022

SELL
$269.58 - $378.88 $4.09 Million - $5.75 Million
-15,181 Reduced 3.31%
443,441 $168 Million
Q1 2022

May 13, 2022

SELL
$254.45 - $351.06 $10.4 Million - $14.3 Million
-40,744 Reduced 8.16%
458,622 $145 Million
Q4 2021

Feb 14, 2022

BUY
$272.01 - $353.03 $17.8 Million - $23.1 Million
65,492 Added 15.09%
499,366 $175 Million
Q3 2021

Nov 15, 2021

SELL
$295.0 - $350.58 $346,625 - $411,931
-1,175 Reduced 0.27%
433,874 $131 Million
Q2 2021

Aug 16, 2021

SELL
$257.11 - $319.92 $7.78 Million - $9.68 Million
-30,266 Reduced 6.5%
435,049 $131 Million
Q1 2021

May 13, 2021

SELL
$268.3 - $380.31 $1.37 Million - $1.94 Million
-5,103 Reduced 1.08%
465,315 $128 Million
Q4 2020

Feb 12, 2021

SELL
$248.13 - $308.36 $227,783 - $283,074
-918 Reduced 0.19%
470,418 $138 Million
Q3 2020

Nov 12, 2020

BUY
$215.51 - $272.51 $1.36 Million - $1.72 Million
6,311 Added 1.36%
471,336 $124 Million
Q2 2020

Aug 13, 2020

BUY
$127.44 - $232.72 $12.8 Million - $23.4 Million
100,414 Added 27.54%
465,025 $105 Million
Q1 2020

May 13, 2020

SELL
$108.83 - $165.23 $891,317 - $1.35 Million
-8,190 Reduced 2.2%
364,611 $48 Million
Q3 2019

Nov 14, 2019

SELL
$113.31 - $150.51 $125,887 - $167,216
-1,111 Reduced 0.3%
372,801 $42.5 Million
Q2 2019

Aug 14, 2019

SELL
$115.0 - $141.58 $458,850 - $564,904
-3,990 Reduced 1.06%
373,912 $52.9 Million
Q1 2019

May 10, 2019

SELL
$98.85 - $134.59 $55.6 Million - $75.7 Million
-562,168 Reduced 59.8%
377,902 $47.2 Million
Q4 2018

Feb 13, 2019

SELL
$63.81 - $109.82 $1.35 Million - $2.33 Million
-21,206 Reduced 2.21%
940,070 $90.3 Million
Q3 2018

Nov 13, 2018

BUY
$75.5 - $96.63 $10.5 Million - $13.4 Million
138,531 Added 16.84%
961,276 $72.9 Million
Q2 2018

Aug 10, 2018

BUY
$74.84 - $100.16 $1.7 Million - $2.28 Million
22,745 Added 2.84%
822,745 $68.2 Million
Q4 2017

Feb 14, 2018

BUY
$22.57 - $63.56 $7.9 Million - $22.2 Million
350,000 Added 77.78%
800,000 $0
Q3 2017

Nov 13, 2017

BUY
$19.81 - $22.61 $8.91 Million - $10.2 Million
450,000
450,000 $10.1 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.9B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.